Loading...
Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia
BACKGROUND: Acquired aplastic anemia results from immune-mediated destruction of bone marrow. Immunosuppressive therapies are effective, but reduced numbers of residual stem cells may limit their efficacy. In patients with aplastic anemia that was refractory to immunosuppression, eltrombopag, a synt...
Saved in:
| Published in: | N Engl J Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5548296/ https://ncbi.nlm.nih.gov/pubmed/28423296 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1613878 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|